Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 9

Results: 41

A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1613, doi. 10.1038/sj.leu.2403821

By:

Robin, M.;
Guardiola, P.;
Devergie, A.;
Yeshurun, M.;
Shapiro, S.;
Esperou, H.;
Ribaud, P.;
Rocha, V.;
Gluckman, E.;
Socié, G.

Publication type:

Article

An amino-acid switch in the BCR-ABL kinase domain modifies sensitivity to imatinib mesylate.

Published in:

2005

By:

Leguay, T.;
Desplat, V.;
Lagarde, V.;
Marit, G.;
Reiffers, J.;
Mahon, F.-X.

Publication type:

Letter

Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.

Published in:

2005

By:

Gottardo, N. G.;
Jacoby, P. A.;
Sather, H. N.;
Reaman, G. H.;
Baker, D. L.;
Kees, U. R.

Publication type:

Letter

p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.

Published in:

2005

By:

Rassidakis, G. Z.;
Thomaides, A.;
Wang, S.;
Jiang, Y.;
Fourtouna, A.;
Lai, R.;
Medeiros, L. J.

Publication type:

journal article

CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients.

Published in:

2005

By:

la Starza, R.;
Aventin, A.;
Crescenzi, B.;
Gorello, P.;
Specchia, G.;
Cuneo, A.;
Angioni, A.;
Bilhou-Nabera, C.;
Boqué, C.;
Foà, R.;
Uyttebroeck, A.;
Talmant, P.;
Cimino, G.;
Martelli, M. F.;
Marynen, P.;
Mecucci, C.;
Hagemeijer, A.

Publication type:

Letter

Clonal selection in the bone marrow involvement of follicular lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1656, doi. 10.1038/sj.leu.2403844

By:

Bognár, Á;
Csernus, B.;
Bödör, C.;
Reiniger, L.;
Szepesi, Á;
Tóth, E.;
Kopper, L.;
Matolcsy, A.

Publication type:

Article

Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1550, doi. 10.1038/sj.leu.2403845

By:

Kornblau, S. M.;
Womble, M.;
Cade, J. S.;
Lemker, E.;
Qiu, Y. H.

Publication type:

Article

Theoretical basis for maintenance therapy of childhood ALL.

Published in:

2005

By:

Campbell, K.

Publication type:

Letter

Acute lymphoblastic leukemia in a patient with congenital neutropenia without G-CSF-R and ELA2 mutations.

Published in:

2005

By:

Yetgin, S.;
Germeshausen, M.;
Touw, I.;
Koç, A.;
Olcay, L.

Publication type:

Letter

Enhanced growth suppression of Philadephia<sup>1</sup> leukemia cells by targeting bcr3/abl2 and VEGF through antisense strategy.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1517, doi. 10.1038/sj.leu.2403851

By:

Cong, X. L.;
Li, B.;
Yang, R. C.;
Feng, S. Z.;
Chen, S. J.;
Han, Z. C.

Publication type:

Article

Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1525, doi. 10.1038/sj.leu.2403852

By:

Ribatti, D.;
Vacca, A.

Publication type:

Article

Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1590, doi. 10.1038/sj.leu.2403853

By:

Zong, Y.;
Zhou, S.;
Sorrentino, B. P.

Publication type:

Article

Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effect.

Published in:

2005

By:

Paubelle, E.;
Coppo, P.;
Garderet, L.;
Azizi, L.;
Bories, D.;
Gorin, N.-C.;
Fouillard, L.

Publication type:

Letter

Chronic graft-versus-host disease: where is promise for the future?

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1532, doi. 10.1038/sj.leu.2403856

By:

Weisdorf, D. J.

Publication type:

Article

Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1634, doi. 10.1038/sj.leu.2403857

By:

Ross, F. M.;
Ibrahim, A. H.;
Vilain-Holmes, A.;
Winfield, M. O.;
Chiecchio, L.;
Protheroe, R. K. M.;
Strike, P.;
Gunasekera, J. L.;
Jones, A.;
Harrison, C. J.;
Morgan, G. J.;
Cross, N. C. P.

Publication type:

Article

Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently.

Published in:

2005

By:

Milojkovic, D.;
Buggins, A. G. S.;
Devereux, S.;
Thomas, N. S. B.;
Mufti, G. J.

Publication type:

Letter

Discrimination of biclonal B-cell chronic lymphoproliferative neoplasias by tetraspanin antigen expression.

Published in:

2005

By:

Barrena, S.;
Almeida, J.;
Yunta, M.;
López, A.;
Díaz-Mediavilla, J.;
Orfao, A.;
Lazo, P. A.

Publication type:

Letter

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1621, doi. 10.1038/sj.leu.2403860

By:

Hus, I.;
Roliński, J.;
Tabarkiewicz, J.;
Wojas, K.;
Bojarska-Junak, A.;
Greiner, J.;
Giannopoulos, K.;
Dmoszyńska, A.;
Schmitt, M.

Publication type:

Article

Induction of centrosome and chromosome aberrations by imatinib in vitro.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1573, doi. 10.1038/sj.leu.2403861

By:

Fabarius, A.;
Giehl, M.;
Frank, O.;
Duesberg, P.;
Hochhaus, A.;
Hehlmann, R.;
Seifarth, W.

Publication type:

Article

C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12.

Published in:

2005

By:

Honczarenko, M.;
Lu, B.;
Nicholson-Weller, A.;
Gerard, N. P.;
Silberstein, L. E.;
Gerard, C.

Publication type:

Letter

Reply to ‘C5L2 receptor is not involved in C3a/C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12’ by Honczarenko et al.

Published in:

2005

By:

Ratajczak, M. Z.;
Reca, R.;
Wysoczynski, M.

Publication type:

Letter

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1543, doi. 10.1038/sj.leu.2403859

By:

Ricciardi, M. R.;
McQueen, T.;
Chism, D.;
Milella, M.;
Estey, E.;
Kaldjian, E.;
Sebolt-Leopold, J.;
Konopleva, M.;
Andreeff, M.

Publication type:

Article

Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1628, doi. 10.1038/sj.leu.2403866

By:

van Valckenborgh, E.;
Mincher, D.;
di Salvo, A.;
van Riet, I.;
Young, L.;
van Camp, B.;
Vanderkerken, K.

Publication type:

Article

Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells.

Published in:

2005

By:

Yu, C.;
Dasmahapatra, G.;
Dent, P.;
Grant, S.

Publication type:

journal article

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1536, doi. 10.1038/sj.leu.2403870

By:

Goemans, B. F.;
Zwaan, Ch. M.;
Miller, M.;
Zimmermann, M.;
Harlow, A.;
Meshinchi, S.;
Loonen, A. H.;
Hählen, K.;
Reinhardt, D.;
Creutzig, U.;
Kaspers, G. J. L.;
Heinrich, M. C.

Publication type:

Article

Mesenchymal stem cells induce apoptosis of activated T cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1597, doi. 10.1038/sj.leu.2403871

By:

Plumas, J.;
Chaperot, L.;
Richard, M.-J.;
Molens, J.-P.;
Bensa, J.-C.;
Favrot, M.-C.

Publication type:

Article

Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia.

Published in:

2005

By:

Roy, L.;
Guilhot, J.;
Martineau, G.;
Larchée, R.;
Guilhot, F.

Publication type:

Letter

Involvement of transforming growth factor-β and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1558, doi. 10.1038/sj.leu.2403875

By:

Akiyama, T.;
Matsunaga, T.;
Terui, T.;
Miyanishi, K.;
Tanaka, I.;
Sato, T.;
Kuroda, H.;
Takimoto, R.;
Takayama, T.;
Kato, J.;
Yamauchi, N.;
Kogawa, K.;
Sakamaki, S.;
Hirayama, Y.;
Kohda, K.;
Niitsu, Y.

Publication type:

Article

Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1567, doi. 10.1038/sj.leu.2403876

By:

Amin, H. M.;
Yang, Y.;
Shen, Y.;
Estey, E. H.;
Giles, F. J.;
Pierce, S. A.;
Kantarjian, H. M.;
O'Brien, S. M.;
Jilani, I.;
Albitar, M.

Publication type:

Article

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL – implications for treatment.

Published in:

2005

By:

Stergianou, K.;
Fox, C.;
Russell, N. H.

Publication type:

Letter

Comparative sequence analysis of incomplete DJH and TCR gene rearrangements in children with relapses of T-ALL.

Published in:

2005

By:

Germano, G.;
del Giudice, L.;
lo Nigro, L.;
Polato, K.;
Giarin, E.;
Paganin, M.;
Basso, G.

Publication type:

Letter

PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation.

Published in:

2005

By:

Murati, A.;
Gelsi-Boyer, V.;
Adélaïde, J.;
Perot, C.;
Talmant, P.;
Giraudier, S.;
Lodé, L.;
Letessier, A.;
Delaval, B.;
Brunel, V.;
Imbert, M.;
Garand, R.;
Xerri, L.;
Birnbaum, D.;
Mozziconacci, M. J.;
Chaffanet, M.

Publication type:

Letter

RT-PCR analysis of p73 splice variants, ease or tease?

Published in:

2005

By:

Niemantsverdriet, M.;
Vermeij, W. P.;
Backendorf, C.

Publication type:

Letter

Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1605, doi. 10.1038/sj.leu.2403881

By:

Yao, Q.;
Nishiuchi, R.;
Kitamura, T.;
Kersey, J. H.

Publication type:

Article

Mutation in RAP1 is a rare event in myelodysplastic syndromes.

Published in:

2005

By:

Gyan, E.;
Frew, M.;
Bowen, D.;
Beldjord, C.;
Preudhomme, C.;
Lacombe, C.;
Mayeux, P.;
Dreyfus, F.;
Porteu, F.;
Fontenay, M.

Publication type:

Letter

Prolonged molecular remission in PML-RARα-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.

Published in:

2005

By:

McMullin, M. F.;
Nugent, E.;
Thompson, A.;
Hull, D.;
Jones, F. G. C.;
Grimwade, D.

Publication type:

Letter

Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.

Published in:

2005

By:

Cerveny, C. G.;
Law, C.-L.;
McCormick, R. S.;
Lenox, J. S.;
Hamblett, K. J.;
Westendorf, L. E.;
Yamane, A. K.;
Petroziello, J. M.;
Francisco, J. A.;
Wahl, A. F.

Publication type:

journal article

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1509, doi. 10.1038/sj.leu.2403886

By:

Lee, K.-H.;
Lee, J.-H.;
Choi, S.-J.;
Seol, M.;
Lee, Y.-S.;
Kim, W.-K.;
Lee, J.-S.;
Seo, E.-J.;
Jang, S.;
Park, C.-J.;
Chi, H.-S.

Publication type:

Article

The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107.

Published in:

2005

By:

von Bubnoff, N.;
Gorantla, S. H. P.;
Kancha, R. K.;
Lordick, F.;
Peschel, C.;
Duyster, J.

Publication type:

Letter

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 9, p. 1643, doi. 10.1038/sj.leu.2403888

By:

Mussolin, L.;
Pillon, M.;
d'Amore, E. S.;
Santoro, N.;
Lombardi, A.;
Fagioli, F.;
Zanesco, L.;
Rosolen, A.

Publication type:

Article

Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation.

Published in:

2005

By:

Nanri, T;
Matsuno, N;
Kawakita, T;
Mitsuya, H;
Asou, N

Publication type:

Letter